إعلان
إعلان

INDP

INDP logo

Indaptus Therapeutics, Inc. Common Stock

2.99
USD
برعاية
+0.30
+11.15%
٠٨ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

3.01

+0.02
+0.70%

تقارير أرباح INDP

النسبة الإيجابية المفاجئة

INDP تفوق 23 من 39 آخر التقديرات.

59%

التقرير التالي

بيانات التقرير القادم
١٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$4.44
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
+48.99%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-58.27%

Indaptus Therapeutics, Inc. Common Stock earnings per share and revenue

On ١٢ نوفمبر ٢٠٢٥, INDP reported earnings of -2.98 USD per share (EPS) for Q3 25, beating the estimate of -4.25 USD, resulting in a 29.94% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +6.25% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -4.44 USD, with revenue projected to reach -- USD, implying an زيادة of 48.99% EPS, and زيادة of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
٢٦ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.49
الفعلي
-
مفاجئة
-
الأسئلة الشائعة
For Q3 2025, Indaptus Therapeutics, Inc. Common Stock reported EPS of -$2.98, beating estimates by 29.94%, and revenue of $0.00, 0% as expectations.
The stock price moved up 6.25%, changed from $2.72 before the earnings release to $2.89 the day after.
The next earning report is scheduled for ١٠ مارس ٢٠٢٦.
Based on 3 المحللين, Indaptus Therapeutics, Inc. Common Stock is expected to report EPS of -$4.44 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان